Evidence map›Paper›PMID 26881821›Full record

ArticleArthritis care & research2016

Defining an International Standard Set of Outcome Measures for Patients With Hip or Knee Osteoarthritis: Consensus of the International Consortium for Health Outcomes Measurement Hip and Knee Osteoarthritis Working Group.

Ola Rolfson, Stephanie Wissig, Lisa van Maasakkers, Caleb Stowell, Ilana Ackerman, David Ayers, Thomas Barber, Thami Benzakour, Kevin Bozic, Nicolaas Budhiparama and 14 more

Abstract readConsensus Statement
In one paragraph

Article in Arthritis care & research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Ola RolfsonInternational Consortium for Health Outcomes Measurement, Cambridge, Massachusetts, Harris Orthopaedic Laboratory, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, and Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. ola.rolfson@vgregion.se.
Stephanie WissigInternational Consortium for Health Outcomes Measurement, Cambridge, Massachusetts.
Lisa van MaasakkersInternational Consortium for Health Outcomes Measurement, Cambridge, Massachusetts.
Caleb StowellInternational Consortium for Health Outcomes Measurement, Cambridge, Massachusetts.
Ilana AckermanUniversity of Melbourne, Melbourne, Victoria, Australia.
David AyersUniversity of Massachusetts Medical School, Worchester.
Thomas BarberKaiser Permanente, Oakland, California.
Thami BenzakourZerktouni Orthopedic Clinic, Casablanca, Morocco.
Kevin BozicDell Medical School, University of Texas at Austin.
Nicolaas BudhiparamaNicolaas Institute of Constructive Orthopaedic Research and Education Foundation for Arthroplasty and Sports Medicine, Medistra Hospital, Jakarta, Indonesia.
James CaillouetteHoag Orthopedic Institute, Newport Beach, California.
Philip G ConaghanUniversity of Leeds and National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.
Leif DahlbergLund University, Lund, Sweden.
Jennifer DunnUniversity of Otago, Dunedin, New Zealand.
John Grady-BensonConnecticut Joint Replacement Institute, Hartford.
Said A IbrahimUniversity of Pennsylvania Perelman School of Medicine, Philadelphia.
Sally LewisAneurin Bevan Health Board, Newport, Wales, UK.
Henrik MalchauSahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, and Harris Orthopaedic Laboratory, Massachusetts General Hospital, and Harvard Medical School, Boston.
Mojieb ManzaryThe Johns Hopkins Aramco Health Care Center, Dhahran, Saudi Arabia.
Lyn MarchNorth Sydney Orthopaedic and Sports Medicine Centre and University of Sydney Institute of Bone and Joint, Royal North Shore Hospital, North Sydney, New South Wales, Australia.
Nader NassifHoag Orthopedic Institute, Newport Beach, California.
Rob NelissenUniversity of Leiden, Leiden, The Netherlands.
Noel SmithArthritis Victoria, Elsternwick, Victoria, Australia.
Patricia D FranklinUniversity of Massachusetts Medical School, Worchester.

Funding

Improving Orthopedic Outcomes Through a National TJR RegistryP50HS018910 · AHRQ · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FRANKLIN, PATRICIA D · 2010 to 2013
$11.9M
AHRQ HHS P50 HS018910
6 · The paper itself

Abstract

objectiveTo define a minimum Standard Set of outcome measures and case-mix factors for monitoring, comparing, and improving health care for patients with clinically diagnosed hip or knee osteoarthritis (OA), with a focus on defining the outcomes that matter most to patients.

methodsAn international working group of patients, arthroplasty register experts, orthopedic surgeons, primary care physicians, rheumatologists, and physiotherapists representing 10 countries was assembled to review existing literature and practices for assessing outcomes of pharmacologic and nonpharmacologic OA therapies, including surgery. A series of 8 teleconferences, incorporating a modified Delphi process, were held to reach consensus.

resultsThe working group reached consensus on a concise set of outcome measures to evaluate patients' joint pain, physical functioning, health-related quality of life, work status, mortality, reoperations, readmissions, and overall satisfaction with treatment result. To support analysis of these outcome measures, pertinent baseline characteristics and risk factor metrics were defined. Annual outcome measurement is recommended for all patients.

conclusionWe have defined a Standard Set of outcome measures for monitoring the care of people with clinically diagnosed hip or knee OA that is appropriate for use across all treatment and care settings. We believe this Standard Set provides meaningful, comparable, and easy to interpret measures ready to implement in clinics and/or registries globally. We view this set as an initial step that, when combined with cost data, will facilitate value-based health care improvements in the treatment of hip and knee OA.

Indexed as

Disease ManagementHumansOsteoarthritis, HipOsteoarthritis, KneeOutcome Assessment, Health CareRisk FactorsTreatment Outcome

Identifiers

PMID26881821
PMCPMC5129496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.